Yes correct. Again I do not care what they do in the short term. I think both of these names have growth. Hell look at CPRX they trade at 1X annual earnings for Firdapse and that is only on the LEMS application. That does not include CMS or myasthenia gravis. They have 80 million in cash and no debt. Should submit their NDA any day now IMO. Approval and this one goes much higher. Hell the best part about it is that the drug is already being given out to patience it just does not have an approval by the FDA yet. But CPRX is looking like they could get it and that will make them the exclusive supplier of the drug for 7 years. Being its already being given out they will not have to put a bunch of time and money into selling it.